Structured evidence table for Olive Oil Cardiometabolic Markers Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Olive Oil Cardiometabolic Markers Randomized Trial | This cross-sectional study analysed whether metabolic profile modifies the associations between chocolate consumption and cardiometabolic risk markers in 1960 adults from the SALMANTICOR population-based cohort. | 4 | Martín-Carro B (2026) | Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study. |
| Olive Oil Cardiometabolic Markers Randomized Trial | In multivariable models without interaction terms, both dark and milk chocolate consumption were associated with lower BMI, whereas dark chocolate consumption was associated with higher LDL cholesterol. | 4 | Martín-Carro B (2026) | Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study. |
| Olive Oil Cardiometabolic Markers Randomized Trial | Among individuals with diabetes, dark chocolate consumption was associated with lower fasting glucose and HbA1c, whereas milk chocolate consumption was associated with lower HbA1c compared with non-consumption. | 4 | Martín-Carro B (2026) | Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study. |
| Olive Oil Cardiometabolic Markers Randomized Trial | Background/Objectives : Studies evaluating the association between chocolate consumption and cardiometabolic health have reported inconsistent findings, and whether these associations differ according to underlying metabolic status remains unclear. | 4 | Martín-Carro B (2026) | Associations Between Chocolate Consumption and Cardiometabolic Risk Markers Across Metabolic Profiles: Insights from a Population-Based Study. |
| Olive Oil Cardiometabolic Markers Randomized Trial | Olive oil, particularly virgin (VOO) and extra-virgin olive oil (EVOO), is a central component of the Mediterranean diet and has been associated with cardiometabolic, anti-inflammatory, and intestinal health benefits. | 4 | Barrera-Chamorro L (2026) | Olive Oil as a Modulator of Gut Microbiota and Intestinal Health: A Narrative Review from Microbial Metabolism to Host Responses. |
| Olive Oil Cardiometabolic Markers Randomized Trial | Increasing evidence suggests that these effects may involve interactions with the gut microbiota, intestinal barrier, and host inflammatory pathways. | 4 | Barrera-Chamorro L (2026) | Olive Oil as a Modulator of Gut Microbiota and Intestinal Health: A Narrative Review from Microbial Metabolism to Host Responses. |
| Olive Oil Cardiometabolic Markers Randomized Trial | This narrative review summarizes current evidence on the impact of olive oil, olive-derived phenolics, and olive oil-rich dietary patterns on gut microbiota modulation, barrier function, inflammatory bowel diseases, and related systemic outcomes. | 4 | Barrera-Chamorro L (2026) | Olive Oil as a Modulator of Gut Microbiota and Intestinal Health: A Narrative Review from Microbial Metabolism to Host Responses. |
Source documents